Lysergic acid diethylamide-derived excitatory/inhibitory ratio change enhances global synchrony in functional brain dynamics. [PDF]
Zhang L +9 more
europepmc +1 more source
Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice. [PDF]
Effinger DP +8 more
europepmc +1 more source
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. [PDF]
Dos Santos RG +5 more
europepmc +1 more source
Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review. [PDF]
Liszka P +9 more
europepmc +1 more source
Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial. [PDF]
Dolder PC, Liechti ME, Rentsch KM.
europepmc +1 more source
Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. [PDF]
Dominiak M +4 more
europepmc +1 more source
Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover Study. [PDF]
Arikci D +7 more
europepmc +1 more source
A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry. [PDF]
Raza M, Kaur J.
europepmc +1 more source
Traces of Use: Uncovering Drug Use Insights From Paraphernalia Analysis. [PDF]
Keller EL +5 more
europepmc +1 more source

